Deep Track Capital »

Ataibeckley shares owned by Deep Track Capital

Quarter-by-quarter ownership of Ataibeckley (ATAI) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Ataibeckley

Tip: Access up to 7 years of quarterly data

All positions including Ataibeckley held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ataibeckley by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $43M 12M 3.54

More positions owned by Deep Track Capital

Spdr Series Trust State Street Spd Put Option (XBI)
Guardant Health (GH)
Immunovant (IMVT)
Tarsus Pharmaceuticals (TARS)
Vaxcyte (PCVX)
Structure Therapeutics Sponsored Ads (GPCR)
Axsome Therapeutics (AXSM)
Apellis Pharmaceuticals (APLS)
Ocular Therapeutix (OCUL)
Vera Therapeutics Cl A (VERA)
Alumis (ALMS)
Ionis Pharmaceuticals (IONS)
Nuvalent Inc-a (NUVL)
Alkermes SHS (ALKS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Deep Track Capital

Top funds holding Ataibeckley

Deep Track Capital
Vanguard Capital Management
UBS Group
BlackRock
Millennium Management
Morgan Stanley
Candriam Luxembourg S.C.A.
Foresite Capital Management VI
Marshall Wace
Geode Capital Management
Two Sigma Investments
Newtyn Management
Eagle Health Investments
Vanguard Fiduciary Trust
Moore Capital Management

View all funds holding Ataibeckley